Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Outset Medical (Nasdaq: OM) reported inducement equity awards approved by its Compensation Committee under Nasdaq Listing Rule 5635(c)(4) for two new hires.

Rhea-AI Summary

Outset Medical (Nasdaq: OM) reported inducement equity awards approved by its Compensation Committee under Nasdaq Listing Rule 5635(c)(4) for two new hires. The Company granted 96,000 RSUs to Derick Elliott, EVP of Commercial, and 10,380 RSUs to another new non-executive employee.

The RSUs vest over three years: 33.33% at the one-year anniversary and the remaining 66.67% in quarterly installments thereafter, subject to continued service and usual acceleration or forfeiture terms.

Positive

• 96,000 RSUs granted to newly appointed EVP of Commercial
• Vesting schedule aligns incentives with three-year commercial leadership tenure

Negative

• Equity awards increase outstanding share-based compensation and may dilute existing shareholders

Argus Apr 9 session

+2.86% close to close Open Argus

Details

News Market Reaction – OM

In the Apr 9 session, OM gained 2.86%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details Nasdaq Rule 5635(c)(4) inducement grants of 96,000 and 10,380 RSUs to a ne...

Analysis

This announcement details Nasdaq Rule 5635(c)(4) inducement grants of 96,000 and 10,380 RSUs to a new EVP of Commercial and a non-executive hire, vesting over three years. It underscores management’s use of equity to attract talent without altering previously disclosed fundamentals. In context of recent earnings, FDA clearance, and ownership filings, this is a routine HR and compensation event. Investors may primarily monitor future operational updates and regulatory milestones for more material catalysts.

Key Figures

RSUs granted (Elliott): 96,000 RSUs RSUs granted (employee): 10,380 RSUs Vesting period: 3 years +2 more

RSUs granted (Elliott)

96,000 RSUs

Inducement grant to EVP Commercial under Inducement Plan

RSUs granted (employee)

10,380 RSUs

Inducement grant to newly appointed non-executive employee

Vesting period

3 years

RSUs vest over three years, subject to continued service

Initial vesting tranche

33.33%

Vests on one-year anniversary of each employee’s start date

Remaining vesting

66.67%

Vests in quarterly installments after first anniversary

Historical Context

5 past events · Latest: Feb 11

5 events

1. Feb 11

   Earnings results

   24h Move

   -16.3%

   Q4 and 2025 results with revenue growth, margin expansion, guidance and cash update.

2. Jan 27

   FDA clearance

   24h Move

   +14.3%

   FDA 510(k) clearance for next-generation Tablo hemodialysis platform with cybersecurity focus.

3. Jan 26

   Earnings date

   24h Move

   +14.3%

   Announcement of timing and webcast details for upcoming Q4 and full-year 2025 results.

4. Jan 12

   Prelim results

   24h Move

   +22.1%

   Unaudited Q4 and 2025 revenue, cash balance, lower cash burn, and board change.

5. Jan 05

   Conference appearance

   24h Move

   +12.9%

   Planned presentation by CEO at the J.P. Morgan Healthcare Conference with webcast access.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nasdaq listing rule 5635(c)(4), inducement plan, restricted stock units, rsus

4 terms

nasdaq listing rule 5635(c)(4) regulatory

"approved equity awards under the Company’s Inducement Plan, as a material inducement ... in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

inducement plan financial

"approved equity awards under the Company’s Inducement Plan, as a material inducement to employment"

An inducement plan is a program a company creates to encourage employees or new hires to stay or join by offering special benefits or rewards. It’s like a company giving extra bonuses or perks to persuade someone to choose their job over others, helping the company attract and keep talented workers.

restricted stock units financial

"The equity awards for the two employees were granted in the form of restricted stock units (“RSUs”)"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

rsus financial

"with 96,000 RSUs granted to Mr. Elliott and 10,380 RSUs granted to the other non-executive employee"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company’s Inducement Plan, as a material inducement to employment to Derick Elliott, the Company’s newly appointed Executive Vice President of Commercial, as well as one newly appointed non-executive employee, in each case, who were not previous employees or directors of the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of any equity awards that are not made under a stockholder approved equity plan.

The equity awards for the two employees were granted in the form of restricted stock units (“RSUs”), with 96,000 RSUs granted to Mr. Elliott and 10,380 RSUs granted to the other non-executive employee. The RSUs will vest over a period of three years, with 33.33% vesting on the one-year anniversary of each employee’s start date and the remaining 66.67% vesting in quarterly installments thereafter, subject to continued service through the applicable vesting dates and subject further to acceleration or forfeiture upon the occurrence of certain events as set forth in each employee’s award agreement.

About Outset Medical, Inc.

Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visit www.outsetmedical.com.

Investor Contact
Jim Mazzola
jmazzola@outsetmedical.com

FAQ

What equity awards did Outset Medical (OM) grant on April 8, 2026?

The company granted 96,000 RSUs to Derick Elliott and 10,380 RSUs to another new hire. According to the company, these awards were made as inducements under Nasdaq Listing Rule 5635(c)(4).

How do the RSUs for OM employees vest and when is the first vesting date?

RSUs vest over three years, with 33.33% vesting at the one-year anniversary. According to the company, the remaining 66.67% vests in quarterly installments thereafter, subject to service and award terms.

Why did Outset Medical (OM) use an inducement grant under Nasdaq Rule 5635(c)(4)?

The inducement grant was used because the recipients were not prior employees or directors. According to the company, Nasdaq Rule 5635(c)(4) permits public issuance of equity awards as material inducements to employment.

Who received the largest inducement RSU award at Outset Medical (OM)?

Derick Elliott, the company’s newly appointed Executive Vice President of Commercial, received the largest award of 96,000 RSUs. According to the company, the award was approved by the Compensation Committee.

What are the investor implications of Outset Medical's (OM) inducement RSU grants?

The grants align new hires with long-term performance but add to share-based compensation and potential dilution. According to the company, vesting is service-based with standard acceleration and forfeiture provisions.